3 stories mentioning SHA:601089Updated 79d ago
Every FINWIRES story that references SHA:601089, newest first.
Beijing Foyou Pharma (SHA:601089) obtained a drug registration certificate from China's National Medical Products Administration for its clopidogrel bisulfate and aspirin tablets, according to a Shanghai bourse filing on Friday.The drug was developed by Sanofi for the secondary prevention of atherothrombotic events.
Beijing Foyou Pharma (SHA:601089) received a drug registration certificate for olmesartan medoxomil orally disintegrating tablets from China's National Medical Products Administration, according to a Shanghai bourse filing on Friday.The drug is used for the treatment of hypertension.
China's drug regulator approved Beijing Foyou Pharma's (SHA:601089) glquidone tablets for type 2 diabetes, according to a Tuesday filing with the Shanghai bourse.The drug is indicated for use together with diet and exercise, the filing said.
